Clofilium tosylate

Suppliers

Names

[ CAS No. ]:
92953-10-1

[ Name ]:
Clofilium tosylate

[Synonym ]:
N-[4-(4-Chlorophenyl)butyl]-N,N-diethyl-1-heptanaminium 4-methylbenzenesulfonate
Benzenebutanaminium,4-chloro-N,N-diethyl-N-heptyl-,salt with 4-methylbenzenesulfonicacid (1:1)
4-Chloro-N,N-diethyl-N-heptylbenzenebutanaminium tosylate
Clofilium tosylate
Prestwick_682

Chemical & Physical Properties

[ Molecular Formula ]:
C28H44ClNO3S

[ Molecular Weight ]:
510.172

[ Exact Mass ]:
509.273041

[ PSA ]:
65.58000

[ LogP ]:
8.46960

[ Storage condition ]:
2-8℃

MSDS

Click to get detail MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CY9040870
CAS REGISTRY NUMBER :
92953-10-1
LAST UPDATED :
198910
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C21-H37-Cl-N.C7-H7-O3-S
MOLECULAR WEIGHT :
510.24

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
456 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NDADD8 New Drugs Annual: Cardiovascular Drugs. (New York, NY) V.1-2, 1983-84. For publisher information, see NCDREP. Volume(issue)/page/year: 2,103,1984
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
416 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NDADD8 New Drugs Annual: Cardiovascular Drugs. (New York, NY) V.1-2, 1983-84. For publisher information, see NCDREP. Volume(issue)/page/year: 2,103,1984

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Faceshields;Gloves

[ Hazard Codes ]:
Xn: Harmful;

[ Risk Phrases ]:
22

[ Safety Phrases ]:
36

[ RIDADR ]:
NONH for all modes of transport

[ RTECS ]:
CY9040870

Articles

Block of heart potassium channels by clofilium and its tertiary analogs: relationship between drug structure and type of channel blocked.

Mol. Pharmacol. 34 , 60-66, (1988)

The whole-cell arrangement of the patch clamp was used to study delayed rectifier and inward rectifier K channels in isolated guinea pig ventricular cells. Block of these channels by an externally app...

The differential response of normal and ischaemic Purkinje fibres to clofilium, d-sotalol and bretylium.

Cardiovasc. Res. 23 , 554-559, (1989)

To determine whether ischaemic tissue is more sensitive than normal tissue to class III anti-arrhythmic agents, we studied the effects of the class III agents clofilium, d-sotalol and bretylium on nor...

Clofilium and other class III agents. Steinberg, et al., Williams, et al.

Handbook of Experimental Pharmacology Berlin Heidelberg 89 , 389, (1989)


More Articles

Related Compounds

  • Clofilium phosphate
  • cycloheptylmethyl tosylate
  • menthyl tosylate
  • BEZ235 (Tosylate)
  • dodecyl tosylate
  • Sitamaquine tosylate
  • 7-Methoxy-2-(propan-2-yl)quinolin-3-ol
  • 7-Chloro-2-cyclobutylquinolin-3-ol
  • 5-Chloro-2-(cyclopropylmethyl)quinolin-3-ol
  • rac-(3R,4S)-4-(3,5-dimethylphenyl)-3-methylpyrrolidin-3-amine
  • tert-butyl N-[5-bromo-4-(methylsulfanyl)pyridin-2-yl]carbamate
  • 3-[1-(2,2,2-Trifluoroacetyl)piperidin-4-yl]-1,2-oxazole-5-carboxylic acid
  • benzyl N-(4-sulfamoylcyclohexyl)carbamate
  • tert-butyl N-{5-[(3-hydroxyazetidin-3-yl)methyl]-2,3-dimethoxyphenyl}carbamate
  • 1-cyclobutanecarbonyl-N-cyclobutylpiperidin-4-amine
  • (1r,3r)-3-[(2-Methylpiperidin-1-yl)methyl]cyclobutan-1-amine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.